| Lastest Insider Transactions Of Atara Biotherapeutics, Inc. ( ATRA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2019-02-15 | Sell | 775 | 39.59 | 30,682 | 2019-02-19 17:08:22 |
| ATRA | Atara Biotherapeutics, Inc. | Porter Derrell | SVP, Head of Global Commercial | 2019-02-15 | Sell | 5,909 | 40.00 | 236,360 | 2019-02-19 17:05:30 |
| ATRA | Atara Biotherapeutics, Inc. | Porter Derrell | SVP, Head of Global Commercial | 2019-02-15 | Option Exercise | 4,000 | 14.30 | 57,200 | 2019-02-19 17:05:30 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2019-02-09 | Sell | 7,800 | 38.77 | 302,367 | 2019-02-12 19:18:27 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2019-02-11 | Sell | 13,975 | 38.55 | 538,736 | 2019-02-11 19:10:23 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2019-02-06 | Sell | 12,375 | 38.62 | 477,922 | 2019-02-08 16:28:15 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2019-02-01 | Sell | 1,500 | 38.01 | 57,020 | 2019-02-01 18:49:08 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2019-02-01 | Option Exercise | 1,500 | 20.40 | 30,600 | 2019-02-01 18:49:08 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2019-01-23 | Sell | 7,800 | 35.06 | 273,433 | 2019-01-25 20:16:56 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2019-01-09 | Sell | 7,800 | 34.55 | 269,470 | 2019-01-10 18:08:04 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2019-01-02 | Sell | 1,500 | 35.00 | 52,500 | 2019-01-02 19:51:09 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2019-01-02 | Option Exercise | 1,500 | 20.40 | 30,600 | 2019-01-02 19:51:09 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-12-27 | Sell | 7,800 | 33.88 | 264,233 | 2018-12-28 18:51:28 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-12-12 | Sell | 7,800 | 42.66 | 332,709 | 2018-12-13 18:58:16 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-12-03 | Sell | 1,500 | 41.14 | 61,704 | 2018-12-03 19:00:20 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-12-03 | Option Exercise | 1,500 | 20.40 | 30,600 | 2018-12-03 19:00:20 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-11-28 | Sell | 7,800 | 40.39 | 315,035 | 2018-11-29 19:39:09 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-11-14 | Sell | 7,800 | 34.62 | 270,052 | 2018-11-15 19:06:49 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-11-15 | Sell | 775 | 33.81 | 26,203 | 2018-11-15 16:53:37 |
| ATRA | Atara Biotherapeutics, Inc. | MARCUS JOEL S | Directior | 2018-11-07 | Sell | 10,000 | 36.35 | 363,500 | 2018-11-08 16:08:47 |
| ATRA | Atara Biotherapeutics, Inc. | MARCUS JOEL S | Directior | 2014-10-21 | Buy | 9,090 | 11.00 | 99,990 | 2018-11-08 16:07:07 |
| ATRA | Atara Biotherapeutics, Inc. | Gallagher Carol Giltner | Directior | 2018-11-07 | Sell | 21,374 | 36.38 | 777,586 | 2018-11-07 19:44:51 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-11-01 | Sell | 1,500 | 35.00 | 52,500 | 2018-11-02 20:15:53 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-11-01 | Option Exercise | 1,500 | 20.40 | 30,600 | 2018-11-02 20:15:53 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-10-22 | Sell | 7,800 | 33.95 | 264,796 | 2018-10-23 18:10:07 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-10-04 | Sell | 7,800 | 40.22 | 313,753 | 2018-10-05 19:45:05 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-10-01 | Sell | 1,500 | 41.28 | 61,918 | 2018-10-02 16:25:31 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-10-01 | Option Exercise | 1,500 | 20.40 | 30,600 | 2018-10-02 16:25:31 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-09-26 | Sell | 13,500 | 43.08 | 581,580 | 2018-09-27 16:56:25 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-09-24 | Sell | 31,500 | 40.17 | 1,265,331 | 2018-09-25 17:02:28 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-09-18 | Sell | 7,800 | 39.80 | 310,479 | 2018-09-20 16:26:06 |
| ATRA | Atara Biotherapeutics, Inc. | Koppikar Utpal | Chief Financial Officer | 2018-07-27 | Buy | 2,000 | 36.80 | 73,600 | 2018-09-11 18:49:12 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-09-06 | Sell | 7,800 | 39.35 | 306,923 | 2018-09-10 16:19:42 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-09-04 | Sell | 1,500 | 39.45 | 59,178 | 2018-09-05 17:28:58 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-09-04 | Option Exercise | 1,500 | 20.40 | 30,600 | 2018-09-05 17:28:58 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-08-20 | Sell | 7,800 | 36.37 | 283,647 | 2018-08-22 16:19:02 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-08-15 | Sell | 775 | 37.54 | 29,094 | 2018-08-16 17:12:09 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-08-06 | Sell | 7,800 | 37.43 | 291,957 | 2018-08-07 17:56:27 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-08-01 | Sell | 1,500 | 37.74 | 56,610 | 2018-08-01 18:21:06 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-08-01 | Option Exercise | 1,500 | 20.40 | 30,600 | 2018-08-01 18:21:06 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-07-30 | Sell | 10,000 | 35.78 | 357,787 | 2018-07-31 17:08:49 |
| ATRA | Atara Biotherapeutics, Inc. | Newell Joe | Chief Tech. Operations Officer | 2018-07-30 | Option Exercise | 10,000 | 20.40 | 204,000 | 2018-07-31 17:08:49 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-07-26 | Sell | 7,800 | 38.00 | 296,432 | 2018-07-30 16:43:08 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-07-09 | Sell | 58,400 | 40.00 | 2,335,739 | 2018-07-11 16:09:49 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-06-26 | Sell | 6,400 | 39.60 | 253,425 | 2018-06-27 19:15:39 |
| ATRA | Atara Biotherapeutics, Inc. | Gallagher Carol Giltner | Directior | 2018-06-18 | Sell | 2,500 | 44.78 | 111,944 | 2018-06-19 16:35:06 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-06-05 | Sell | 8,800 | 48.56 | 427,288 | 2018-06-06 19:18:35 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-05-21 | Sell | 8,800 | 51.74 | 455,313 | 2018-05-22 19:02:27 |
| ATRA | Atara Biotherapeutics, Inc. | Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-05-18 | Sell | 25,860 | 50.03 | 1,293,776 | 2018-05-21 18:32:34 |
| ATRA | Atara Biotherapeutics, Inc. | Porter Derrell | SVP, Head of Global Commercial | 2018-05-15 | Sell | 16,334 | 45.02 | 735,357 | 2018-05-16 20:41:56 |
| ATRA | Atara Biotherapeutics, Inc. | Porter Derrell | SVP, Head of Global Commercial | 2018-05-15 | Option Exercise | 16,334 | 14.30 | 233,576 | 2018-05-16 20:41:56 |
| ATRA | Atara Biotherapeutics, Inc. | Fust Matthew K | Directior | 2018-05-14 | Sell | 12,286 | 43.57 | 535,301 | 2018-05-16 20:40:42 |
| ATRA | Atara Biotherapeutics, Inc. | Fust Matthew K | Directior | 2018-05-14 | Option Exercise | 534 | 0.00 | 0 | 2018-05-16 20:40:42 |
| ATRA | Atara Biotherapeutics, Inc. | Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-05-15 | Sell | 4,647 | 46.06 | 214,026 | 2018-05-16 20:38:50 |
| ATRA | Atara Biotherapeutics, Inc. | Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-05-15 | Option Exercise | 4,808 | 0.00 | 0 | 2018-05-16 20:38:50 |
| ATRA | Atara Biotherapeutics, Inc. | Gallagher Carol Giltner | Directior | 2018-05-15 | Sell | 273 | 46.06 | 12,574 | 2018-05-16 20:37:54 |
| ATRA | Atara Biotherapeutics, Inc. | Gallagher Carol Giltner | Directior | 2018-05-15 | Option Exercise | 545 | 0.00 | 0 | 2018-05-16 20:37:54 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-05-15 | Sell | 25,775 | 45.30 | 1,167,480 | 2018-05-16 20:37:01 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-05-15 | Option Exercise | 25,000 | 11.00 | 275,000 | 2018-05-16 20:37:01 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-05-09 | Sell | 8,800 | 39.85 | 350,637 | 2018-05-10 19:46:16 |
| ATRA | Atara Biotherapeutics, Inc. | Porter Derrell | SVP, Head of Global Commercial | 2018-05-08 | Sell | 1,544 | 40.15 | 61,992 | 2018-05-08 20:18:40 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-04-11 | Sell | 8,800 | 41.87 | 368,472 | 2018-04-12 18:14:43 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-03-26 | Sell | 200 | 38.40 | 7,680 | 2018-04-03 18:55:17 |
| ATRA | Atara Biotherapeutics, Inc. | Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-03-29 | Sell | 22,400 | 40.07 | 897,568 | 2018-04-03 16:14:23 |
| ATRA | Atara Biotherapeutics, Inc. | Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-03-27 | Sell | 100,203 | 37.87 | 3,795,062 | 2018-03-28 20:10:08 |
| ATRA | Atara Biotherapeutics, Inc. | Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-03-27 | Option Exercise | 72,754 | 21.85 | 1,589,393 | 2018-03-28 20:10:08 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-03-26 | Sell | 8,800 | 38.59 | 339,549 | 2018-03-27 20:30:15 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-03-26 | Sell | 18,327 | 39.79 | 729,265 | 2018-03-27 16:16:39 |
| ATRA | Atara Biotherapeutics, Inc. | MCGRATH JOHN | EVP & Chief Financial Officer | 2018-03-19 | Sell | 6,000 | 40.41 | 242,460 | 2018-03-20 18:30:36 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-03-15 | Sell | 8,800 | 42.13 | 370,748 | 2018-03-19 16:36:51 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-03-12 | Sell | 1,000 | 46.31 | 46,314 | 2018-03-14 17:23:38 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-02-20 | Sell | 17,800 | 44.65 | 794,733 | 2018-02-22 19:42:53 |
| ATRA | Atara Biotherapeutics, Inc. | Gallagher Carol Giltner | Directior | 2018-02-15 | Sell | 1,183 | 46.50 | 55,010 | 2018-02-20 20:25:40 |
| ATRA | Atara Biotherapeutics, Inc. | Gallagher Carol Giltner | Directior | 2018-02-15 | Option Exercise | 2,365 | 0.00 | 0 | 2018-02-20 20:25:40 |
| ATRA | Atara Biotherapeutics, Inc. | Fust Matthew K | Directior | 2018-02-15 | Option Exercise | 1,603 | 0.00 | 0 | 2018-02-20 20:25:08 |
| ATRA | Atara Biotherapeutics, Inc. | Haqq Christopher | EVP, R&D & Chief Scientific Of | 2018-02-15 | Option Exercise | 553 | 0.00 | 0 | 2018-02-20 20:24:32 |
| ATRA | Atara Biotherapeutics, Inc. | Clark Mitchall G. | EVP & Chief R & QA Officer | 2018-02-15 | Option Exercise | 7,211 | 0.00 | 0 | 2018-02-20 20:23:56 |
| ATRA | Atara Biotherapeutics, Inc. | Soffer Gad | EVP & Chief Strategy Officer | 2018-02-15 | Option Exercise | 2,764 | 0.00 | 0 | 2018-02-20 20:23:22 |
| ATRA | Atara Biotherapeutics, Inc. | MCGRATH JOHN | EVP & Chief Financial Officer | 2018-02-15 | Sell | 13,000 | 47.07 | 611,925 | 2018-02-20 20:22:49 |
| ATRA | Atara Biotherapeutics, Inc. | MCGRATH JOHN | EVP & Chief Financial Officer | 2018-02-15 | Option Exercise | 5,132 | 0.00 | 0 | 2018-02-20 20:22:49 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-02-15 | Sell | 20,000 | 46.92 | 938,459 | 2018-02-20 20:22:07 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-02-15 | Option Exercise | 3,938 | 0.00 | 0 | 2018-02-20 20:22:07 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-02-13 | Sell | 20,000 | 46.80 | 935,956 | 2018-02-14 19:54:39 |
| ATRA | Atara Biotherapeutics, Inc. | Turner Heather D | Former EVP, GC & Sec. | 2018-02-09 | Sell | 12,214 | 38.01 | 464,210 | 2018-02-12 21:00:07 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-02-08 | Sell | 8,800 | 37.44 | 329,429 | 2018-02-12 17:09:00 |
| ATRA | Atara Biotherapeutics, Inc. | Ciechanover Isaac E. | Chief Executive Officer | 2018-01-25 | Sell | 19,300 | 35.26 | 680,534 | 2018-01-29 19:39:02 |
